Allison Overbay, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 827 Slack St, Pea Ridge, AR 72751 Phone: 479-451-9434 |
Alexys Joann Lipscomb Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 979 Weston St, Pea Ridge, AR 72751 Phone: 800-451-0032 |
Tabitha Mayberry, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 827 Slack St, Pea Ridge, AR 72751 Phone: 479-451-9434 Fax: 479-488-6220 |
Mrs. Amanda Mychale Coco Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 781 W Pickens Rd, Pea Ridge, AR 72751 Phone: 479-451-8181 |
Melissa Kucyk Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 979 Weston St, Pea Ridge, AR 72751 Phone: 800-451-0032 |
Courtney Elizabeth Powell, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 535 Nelson Ct, Pea Ridge, AR 72751 Phone: 479-366-7654 |
Mr. Patrick Thompson, MS-CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 781 W Pickens Rd, Pea Ridge, AR 72751 Phone: 800-451-1343 |
News Archive
The first ever WHO Model Formulary for Children released by the WHO provides information on how to use over 240 essential medicines for treating illness and disease in children from 0 to 12 years of age. This means that for the first time medical practitioners worldwide have access to standardized information on the recommended use, dosage, adverse effects, and contraindications of these medicines for use in children.
Lawmakers target Medicare and Medicaid fraud to generate greater savings in health care reform while doctors worry about efforts to cut waste.
Treatment with insulin revolutionized the life of individuals with diabetes. However, because insulin acts to lower blood glucose levels, it can cause hypoglycemia (low levels of glucose in the blood), which, if prolonged, can lead to brain injury and coma.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $218 million, after settling prior advances of approximately $30 million.
› Verified 3 days ago